A New Hope for Epidermolysis Bullosa (“butterfly children”) Thanks to Novel CRISPR-Cas3 Platform
Healiva SA (Healiva) and C4U Corporation (C4U) are pleased to announce that they have entered into a strategic alliance agreement regarding the development of CRISPR-Cas3 derived therapeutic solutions for Epidermolysis Bullosa (EB), also known as “butterfly children”. Epidermolysis bullosa is a rare genetic…
Deciphera Pharmaceuticals Announces Positive Top-line Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) and Updated Results from Phase 1/2 Study of Vimseltinib in TGCT
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced positive top-line results from the MOTION pivotal Phase 3 study of vimseltinib in…
Calidi Biotherapeutics Announces Appointment of Andrew Jackson as Chief Financial Officer
Calidi Biotherapeutics, Inc. (NYSEAM: CLDI) (or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the appointment of Andrew Jackson as Chief Financial Officer. Mr. Jackson is a financial executive with over 25 years of corporate…
Chemed Reports Third-Quarter 2023 Results – Increases Full Year Guidance
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2023,…
AbbVie Reports Third-Quarter 2023 Financial Results
AbbVie (NYSE:ABBV) announced financial results for the third quarter ended September 30, 2023. “We delivered another quarter of outstanding results driven by accelerating performance across our non-Humira growth platform, which is demonstrating double-digit growth,” said Richard A. Gonzalez, chairman and chief executive…
Merck Announces Third-Quarter 2023 Financial Results
RAHWAY, N.J.–(BUSINESS WIRE)– Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2023. “Our strong results this quarter reflect our talented team’s commitment to bringing forward important innovation and…
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive topline results from a Phase 1/2 study (NCT05596734) evaluating the safety, tolerability and immunogenicity of mRNA-based combination vaccine candidates for influenza and COVID-19 among healthy adults 18 to 64 years of…
ATEC Announces Closing of Public Stock Offering
Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the closing of its previously announced underwritten public offering of 14,300,000 shares of its common stock at a public…
2024 MedDev eMarketing Summit (San Diego, CA, United States – May 7-8, 2024) – ResearchAndMarkets.com
The “2024 MedDev eMarketing Summit” conference has been added to ResearchAndMarkets.com’s offering. Now in its 8th year, the popular MedDev eMarketing Summit is back next May 2024 in beautiful San Diego! This is a one-of-a-kind ‘TED-style’ digital marketing leadership storytelling Summit for medical device…
Bruker Announces Date and Time of Third Quarter 2023 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2023 financial results before market opening on Thursday, November 2, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and…
Pramana and Caris Life Sciences Collaborate to Digitize 1.5 Million Pathology Slides Annually
Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, today announced a multi-year agreement with Caris Life Sciences (Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize…
FOXO Technologies Inc. Announces Reverse Stock Split
FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the field of commercializing epigenetic biomarker technology,today announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company’s Class A common stock, par…